Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Stulc

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Nutrition (Burbank, Los Angeles County, Calif.)|August 31, 2001
Folate supplementation prevents plasma homocysteine increase after fenofibrate therapyT Stulc, V Melenovský, B Grauová, et al.
Physiological Research|August 6, 2003
Microvascular reactivity in patients with hypercholesterolemia: effect of lipid lowering treatmentT Stulc, Z Kasalová, M Prázný, et al.
Physiological Research|April 3, 2008
Lower wall shear rate of the common carotid artery in treated type 2 diabetes mellitus with metabolic syndromeE Chytilová, J Malík, Z Kasalová, et al.
Physiological Research|May 1, 2007
Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: the effect of atorvastatin treatmentT Stulc, M Vrablík, Z Kasalová, et al.
Folia Biologica|August 21, 2007
Apolipoprotein E gene polymorphism in the Mongolian populationH Svobodová, F Kucera, T Stulc, et al.
Current Atherosclerosis Reports|June 5, 2020
Statin Intolerance in Clinical PracticeMichaela Snejdrlova, T Altschmiedova, M Vrablik, et al.
Physiological Research|December 20, 2008
The effect of rosiglitazone on the expression of thrombogenic markers on leukocytes in type 2 diabetes mellitusH Svobodová, T Stulc, Z Kasalová, et al.
Physiological Research|November 17, 2004
Decrease in serum dehydroepiandrosterone level after fenofibrate treatment in males with hyperlipidemiaJ Sulcová, T Stulc, M Hill, et al.
Physiological Research|November 8, 2006
Effect of PPAR-gamma agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitusR Doležalová, M M Haluzík, L Bošanská, et al.
Physiological Research|December 7, 2007
Hyperlipidemia is associated with altered levels of insulin-like growth factor-IJ Malík, T Stulc, D Wichterle, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Nutrition (Burbank, Los Angeles County, Calif.)|August 31, 2001
Folate supplementation prevents plasma homocysteine increase after fenofibrate therapyT Stulc, V Melenovský, B Grauová, et al.
Physiological Research|August 6, 2003
Microvascular reactivity in patients with hypercholesterolemia: effect of lipid lowering treatmentT Stulc, Z Kasalová, M Prázný, et al.
Physiological Research|April 3, 2008
Lower wall shear rate of the common carotid artery in treated type 2 diabetes mellitus with metabolic syndromeE Chytilová, J Malík, Z Kasalová, et al.
Physiological Research|May 1, 2007
Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: the effect of atorvastatin treatmentT Stulc, M Vrablík, Z Kasalová, et al.
Folia Biologica|August 21, 2007
Apolipoprotein E gene polymorphism in the Mongolian populationH Svobodová, F Kucera, T Stulc, et al.
Current Atherosclerosis Reports|June 5, 2020
Statin Intolerance in Clinical PracticeMichaela Snejdrlova, T Altschmiedova, M Vrablik, et al.
Physiological Research|December 20, 2008
The effect of rosiglitazone on the expression of thrombogenic markers on leukocytes in type 2 diabetes mellitusH Svobodová, T Stulc, Z Kasalová, et al.
Physiological Research|November 17, 2004
Decrease in serum dehydroepiandrosterone level after fenofibrate treatment in males with hyperlipidemiaJ Sulcová, T Stulc, M Hill, et al.
Physiological Research|November 8, 2006
Effect of PPAR-gamma agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitusR Doležalová, M M Haluzík, L Bošanská, et al.
Physiological Research|December 7, 2007
Hyperlipidemia is associated with altered levels of insulin-like growth factor-IJ Malík, T Stulc, D Wichterle, et al.
Pageof 3